Alimera Sciences Inc
ALIMDelisted Sep 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267602
Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Alimera Sciences Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 18 | 30 | +12 |
| Shares | 3.51M | 47.3M | +43.7M (+1,245.2%) |
| Value | $10.3M | $146.5M | +$136.2M (+1,328.2%) |
New holders (12)
Institutions that held Alimera Sciences Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,983,686 | $12.3M | 4.10% |
| Boothbay Fund Management, LLC | 3,198,708 | $9.92M | 0.35% |
| Altium Capital Management LP | 2,934,108 | $9.10M | 5.26% |
| AIGH Capital Management LLC | 2,372,572 | $7.35M | 3.48% |
| Clearline Capital LP | 2,335,293 | $7.24M | 0.72% |
| Worth Venture Partners, LLC | 593,709 | $1.84M | 1.10% |
| Jefferies Financial Group Inc. | 12,900 | $40.0K | 0.00% |
| Bank of America Corp | 2,500 | $7.75K | 0.00% |
| Citigroup Inc | 1,600 | $4.96K | 0.00% |
| Syntax Research, Inc. | 80 | $248 | 0.00% |
| Barclays PLC | 36 | $112 | 0.00% |
| Comerica Bank | 14 | $43 | 0.00% |
Sold out (0)
Institutions that held Alimera Sciences Inc at the end of Q2 2023 and filed for Q3 2023 without it.
None.